BioSpace News Archive

Exeltis USA, Inc. a division of the global pharmaceutical group Insud Pharma, announced today that the US Food and Drug Administration (FDA) has approved the new drug application (NDA) for Slynd™ (pronounced “slind”) containing drospirenone 4 mg, an oral contraceptive tablet for pregnancy prevention.

Infiniti Research, a market intelligence solutions provider, has recently announced the completion of their recent article on medical devices packaging trends 2019.

At HPFY corporate social responsibility is of great importance. They have successfully launched 27 Giving Days till date, donating over $63k to global causes.

Company expands relationship to bring single sign-on (SSO) access to ClinCard patient reimbursement and ConneX comprehensive travel solutions

US Medical Innovations, LLC, announced that Jerome Canady MD, Chief Executive Officer, USMI, will be presenting “Cold Plasma Oncotherapeutics™ and Robotic Voice-Operated Delivery System.

TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend” or the “Company”) has closed a series of transactions to acquire the California operations of the award-winning retail dispensary brand known as “The Apothecarium” for consideration comprised of US$36.8 million in cash and proportionate voting shares in the equity of TerrAscend equivalent to 6.7mm common shares of the Company.

Dallas-Fort Worth neurosurgeon, James Kevin Kaufman, M.D., has accepted an invitation to speak at the upcoming 2019 Neurorehabilitation Conference on Saturday, June 8th, in Grapevine, TX.

Facility Brings New Depression Treatment Options to Greater Los Angeles

CannTrust Holdings Inc. announced the national launch of its social responsibility platform: We Care.

Harvard Business School (HBS) has named its 2019-2020 Blavatnik Fellows in Life Science Entrepreneurship.